248 related articles for article (PubMed ID: 36248783)
1. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.
Wang C; Huang N; Lu QB; Black S; Liang X; Cui F
Front Immunol; 2022; 13():956473. PubMed ID: 36248783
[TBL] [Abstract][Full Text] [Related]
2. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
3. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
Yu W; Liu D; Zheng J; Liu Y; An Z; Rodewald L; Zhang G; Su Q; Li K; Xu D; Wang F; Yuan P; Xia W; Ning G; Zheng H; Chu Y; Cui J; Duan M; Hao L; Zhou Y; Wu Z; Zhang X; Cui F; Li L; Wang H
Int J Epidemiol; 2016 Apr; 45(2):441-9. PubMed ID: 27174834
[TBL] [Abstract][Full Text] [Related]
4. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
5. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
[TBL] [Abstract][Full Text] [Related]
6. An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
Gidudu JF; Shaum A; Habersaat K; Wilhelm E; Woodring J; Mast E; Zuber P; Amarasinghe A; Nelson N; Kabore H; Abad N; Tohme RA
Vaccine; 2020 Nov; 38(49):7728-7740. PubMed ID: 31337590
[TBL] [Abstract][Full Text] [Related]
7. Analysis of deaths following yeast-derived hepatitis B vaccination of infants, China, January 2013 to December 2020.
Zhang S; Zhao T; Chen L; Xie M; Lu QB; Du J; Zeng J; Huang N; Liu Y; Wang C; Cui F
Front Public Health; 2023; 11():1170483. PubMed ID: 37397780
[TBL] [Abstract][Full Text] [Related]
8. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
9. Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China.
Pan X; Lv H; Liang H; Wang Y; Shen L; Chen F; Chen Y; Hu Y
Hum Vaccin Immunother; 2022 Dec; 18(1):2021711. PubMed ID: 35108152
[TBL] [Abstract][Full Text] [Related]
10. Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.
Giang E; Xu Y; Naganathan T; Abraham N; Bawolak MT; Salim BS; Weeks A; Shaw A; Ogunnaike-Cooke S
Can Commun Dis Rep; 2024 Jan; 50(1-2):16-24. PubMed ID: 38655243
[TBL] [Abstract][Full Text] [Related]
11. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
[TBL] [Abstract][Full Text] [Related]
12. Adverse events following immunization in Ontario's female school-based HPV program.
Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
[TBL] [Abstract][Full Text] [Related]
13. Imprecision in vaccine adverse event reporting and a methodological analysis of reporting systems to improve pharmacovigilance and public health.
Inokuma Y; Kneller R
Eur J Clin Pharmacol; 2023 Jul; 79(7):989-1002. PubMed ID: 37249640
[TBL] [Abstract][Full Text] [Related]
14. [Seroepidemiological analysis of hepatitis B virus infection among adolescents aged 0-14 years in Henan Province and preliminary evaluation of the effectiveness of childhood hepatitis B vaccine immunization program].
Guo YH; Chen YP; Dou QH; Liu Q; Yang JH; Seng MH; Lyu YY; Wang CS; Lu MX; Xu J; Zhang YY; Zhao DY
Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):202-207. PubMed ID: 38387951
[No Abstract] [Full Text] [Related]
15. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
Wattigney WA; Mootrey GT; Braun MM; Chen RT
Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
[TBL] [Abstract][Full Text] [Related]
16. Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019-2023.
Stefanizzi P; Di Lorenzo A; Martinelli A; Moscara L; Stella P; Ancona D; Tafuri S
Vaccine; 2023 Nov; 41(48):7096-7102. PubMed ID: 37891052
[TBL] [Abstract][Full Text] [Related]
17. Safety of concomitant administration of inactivated hepatitis A vaccine with other vaccines in children under 16 years old in post-marketing surveillance.
Wu L; Yang S; Huang Z; Liu J; Guo X; Bai Q; Sun X
Vaccine; 2023 Mar; 41(14):2412-2417. PubMed ID: 36872142
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
Guo B; Page A; Wang H; Taylor R; McIntyre P
Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
[TBL] [Abstract][Full Text] [Related]
20. Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).
Niu MT; Rhodes P; Salive M; Lively T; Davis DM; Black S; Shinefield H; Chen RT; Ellenberg SS
J Clin Epidemiol; 1998 Jun; 51(6):503-10. PubMed ID: 9635999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
